Entering text into the input field will update the search result below

Alimera Sciences Inc. (ALIM) CEO Rick Eiswirth on Q1 2021 Results - Earnings Call Transcript

May 01, 2021 3:30 PM ETAlimera Sciences, Inc. (ALIM)
SA Transcripts profile picture
SA Transcripts

Alimera Sciences Inc. (NASDAQ:ALIM) Q1 2021 Earnings Conference Call April 29, 2021 9:00 AM ET

Company Participants

Scott Gordon - Core IR

Rick Eiswirth - President and Chief Executive Officer

Phil Jones - Chief Financial Officer

Conference Call Participants

Alex Nowak - Craig-Hallum Capital

Yi Chen - H.C. Wainwright

James Molloy - Alliance Global Partners


Ladies and gentlemen, thank you for standing by. Good morning and welcome to Alimera Sciences' First Quarter Fiscal Year 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions]

After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded by a playback-purposes. A webcast replay of the call will be available approximately 1 hour after the end of the call through May 13, 2021.

I would now like to turn the call over to Mr. Scott Gordon of CORE IR, the company's Investor Relations firm. Please go ahead, sir.

Scott Gordon

Good morning and thank you for participating in today's conference call. Joining me from Alimera's leadership team are Rick Eiswirth, President and Chief Executive Officer; and Phil Jones, Chief Financial Officer. During this call, management will be making forward-looking statements including statements that address Alimera's expectations for future performance or operational results. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in Alimera's most recently filed periodic reports on Form 10-K and Form 10-Q, the Form 8-K filed with the SEC today, and Alimera's press release last evening, particularly cautionary statements in it.

Today's conference call includes adjusted EBITDA, a non-GAAP financial measure that

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.